The dynamic properties of the Hepatitis C Virus E2 envelope protein unraveled by molecular dynamics

References

• Allander, T., Drakenberg, K., Beyene, A., Rosa, D., Abrignani, S., Houghton, M., … Persson, M. A. (2000). Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. Journal of General Virology, 81, 2451–2459. [Research Support, Non-U.S. Gov’t]. doi:10.1099/0022-1317-81-10-2451
   PubMed Web of Science ®Google Scholar
• Amadei, A., Ceruso, M. A., & Di Nola, A. (1999). On the convergence of the conformational coordinates basis set obtained by the essential dynamics analysis of proteins’ molecular dynamics simulations. Proteins: Structure, Function, and Genetics, 36, 419–424. [Research Support, Non-U.S. Gov’t].10.1002/(ISSN)1097-0134
   PubMed Web of Science ®Google Scholar
• Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins: Structure, Function, and Genetics, 17, 412–425. [Research Support, Non-U.S. Gov’t]. doi:10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• Ball, J. K., Tarr, A. W., & McKeating, J. A. (2014). The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral Research, 105, 100–111. [Review]. doi:10.1016/j.antiviral.2014.02.013
   PubMed Web of Science ®Google Scholar
• Bowen, D. G., & Walker, C. M. (2005). The origin of quasispecies: Cause or consequence of chronic hepatitis C viral infection? Journal of Hepatology, 42, 408–417. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. doi:10.1016/j.jhep.2004.12.013
   PubMed Web of Science ®Google Scholar
• Cocquerel, L., Wychowski, C., Minner, F., Penin, F., & Dubuisson, J. (2000). Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. Journal of Virology, 74, 3623–3633.[Research Support, Non-U.S. Gov’t]. 10.1128/JVI.74.8.3623-3633.2000
   PubMed Web of Science ®Google Scholar
• Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y. S., … Dubuisson, J. (1997). Formation of native hepatitis C virus glycoprotein complexes. Journal of Virology, 71, 697–704.[Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.].
   PubMed Web of Science ®Google Scholar
• Deng, K., Liu, R., Rao, H., Jiang, D., Wang, J., Xie, X., & Wei, L. (2015). Antibodies targeting novel neutralizing epitopes of hepatitis C virus glycoprotein preclude genotype 2 virus infection. PLoS One, 10, e0138756. [Research Support, Non-U.S. Gov’t]. doi:10.1371/journal.pone.0138756
   Google Scholar
• Deng, L., Ma, L., Virata-Theimer, M. L., Zhong, L., Yan, H., Zhao, Z., … Zhang, P. (2014). Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization. Proceedings of the National academy of Sciences of the United States of America, 111, 10690–10695. [Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. doi:10.1073/pnas.1411317111
   PubMed Web of Science ®Google Scholar
• Deng, L., Zhong, L., Struble, E., Duan, H., Ma, L., Harman, C., … Zhang, P. (2013). Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus. Proceedings of the National academy of Sciences of the United States of America, 110, 7418–7422. [Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. doi:10.1073/pnas.1305306110
   PubMed Web of Science ®Google Scholar
• Drummer, H. E., Boo, I., Maerz, A. L., & Poumbourios, P. (2006). A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry. Journal of Virology, 80, 7844–7853. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.00029-06
   PubMed Web of Science ®Google Scholar
• Drummer, H. E., Wilson, K. A., & Poumbourios, P. (2002). Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. Journal of Virology, 76, 11143–11147.[Research Support, Non-U.S. Gov’t]. 10.1128/JVI.76.21.11143-11147.2002
   PubMed Web of Science ®Google Scholar
• Duan, H., Kachko, A., Zhong, L., Struble, E., Pandey, S., Yan, H., … Zhang, P. (2012). Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein. Journal of Virology, 86, 12686–12694. [Research Support, U.S. Gov’t, P.H.S.]. doi:10.1128/JVI.00994-12
   PubMed Web of Science ®Google Scholar
• Dubuisson, J. (2000). Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Current Topics in Microbiology and Immunology, 242, 135–148. [Research Support, Non-U.S. Gov’t Review].
   PubMed Web of Science ®Google Scholar
• Falkowska, E., Kajumo, F., Garcia, E., Reinus, J., & Dragic, T. (2007). Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. Journal of Virology, 81, 8072–8079. [Research Support, N.I.H., Extramural]. doi:10.1128/JVI.00459-07
   PubMed Web of Science ®Google Scholar
• Flint, M., Thomas, J. M., Maidens, C. M., Shotton, C., Levy, S., Barclay, W. S., & McKeating, J. A. (1999). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. Journal of Virology, 73, 6782–6790. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.].
   PubMed Web of Science ®Google Scholar
• Goffard, A., Callens, N., Bartosch, B., Wychowski, C., Cosset, F. L., Montpellier, C., & Dubuisson, J. (2005). Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. Journal of Virology, 79, 8400–8409. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.79.13.8400-8409.2005
   PubMed Web of Science ®Google Scholar
• Helle, F., Goffard, A., Morel, V., Duverlie, G., McKeating, J., Keck, Z. Y., … Voisset, C. (2007). The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. Journal of Virology, 81, 8101–8111. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.00127-07
   PubMed Web of Science ®Google Scholar
• Helle, F., Vieyres, G., Elkrief, L., Popescu, C. I., Wychowski, C., Descamps, V., … Dubuisson, J. (2010). Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. Journal of Virology, 84, 11905–11915. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.01548-10
   PubMed Web of Science ®Google Scholar
• Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., & McKeating, J. A. (2003). Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proceedings of the National academy of Sciences of the United States of America, 100, 7271–7276. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. doi:10.1073/pnas.0832180100
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38, 27–38. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.].10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Johansson, D. X., Voisset, C., Tarr, A. W., Aung, M., Ball, J. K., Dubuisson, J., & Persson, M. A. (2007). Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proceedings of the National academy of Sciences of the United States of America, 104, 16269–16274. [Research Support, Non-U.S. Gov’t]. doi:10.1073/pnas.0705522104
   PubMed Web of Science ®Google Scholar
• Keck, Z. Y., Xia, J., Wang, Y., Wang, W., Krey, T., Prentoe, J., … Foung, S. K. (2012). Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathogens, 8, e1002653. [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. doi:10.1371/journal.ppat.1002653
   PubMed Web of Science ®Google Scholar
• Khan, A. G., Whidby, J., Miller, M. T., Scarborough, H., Zatorski, A. V., Cygan, A., … Marcotrigiano, J. (2014). Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature, 509, 381–384. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. doi: 10.1038/nature13117
   PubMed Web of Science ®Google Scholar
• Kielian, M. (2006). Class II virus membrane fusion proteins. Virology, 344, 38–47. [Research Support, N.I.H., Extramural Review]. doi: 10.1016/j.virol.2005.09.036
   PubMed Web of Science ®Google Scholar
• Kong, L., Giang, E., Nieusma, T., Kadam, R. U., Cogburn, K. E., Hua, Y., … Law, M. (2013). Hepatitis C virus E2 envelope glycoprotein core structure. Science, 342, 1090–1094. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. doi: 10.1126/science.1243876
   PubMed Web of Science ®Google Scholar
• Kong, L., Giang, E., Nieusma, T., Robbins, J. B., Deller, M. C., Stanfield, R. L., … Law, M. (2012). Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. Journal of Virology, 86, 13085–13088. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. doi:10.1128/JVI.01939-12
   PubMed Web of Science ®Google Scholar
• Kong, L., Giang, E., Robbins, J. B., Stanfield, R. L., Burton, D. R., Wilson, I. A., & Law, M. (2012). Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proceedings of the National academy of Sciences of the United States of America, 109(24), 9499–9504. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. doi:10.1073/pnas.1202924109
   PubMed Web of Science ®Google Scholar
• Kong, L., Jackson, K. N., Wilson, I. A., & Law, M. (2015). Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design. Current Opinion in Virology, 11, 148–157. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review]. doi:10.1016/j.coviro.2015.04.001
   PubMed Web of Science ®Google Scholar
• Krey, T., Meola, A., Keck, Z. Y., Damier-Piolle, L., Foung, S. K., & Rey, F. A. (2013). Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape. PLoS Pathogens, 9, e1003364. [Research Support, Non-U.S. Gov’t]. doi:10.1371/journal.ppat.1003364
   PubMed Web of Science ®Google Scholar
• Kwong, A. D., Mcnair, L., Jacobson, I., & George, S. (2008). Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors. Current Opinion in Pharmacology, 8, 522–531. [Review]. doi:10.1016/j.coph.2008.09.007
   PubMed Web of Science ®Google Scholar
• Law, M., Maruyama, T., Lewis, J., Giang, E., Tarr, A. W., Stamataki, Z., … Burton, D. R. (2008). Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nature Medicine, 14, 25–27. [Research Support, Non-U.S. Gov’t]. doi:10.1038/nm1698
   PubMed Web of Science ®Google Scholar
• Li, Y., Pierce, B. G., Wang, Q., Keck, Z. Y., Fuerst, T. R., Foung, S. K., & Mariuzza, R. A. (2015). Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody. Journal of Biological Chemistry, 290, 10117–10125. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. doi:10.1074/jbc.M115.643528
   PubMed Web of Science ®Google Scholar
• Mancini, N., Diotti, R. A., Perotti, M., Sautto, G., Clementi, N., Nitti, G., … Burioni, R. (2009). Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PLoS One, 4, e8254. doi:10.1371/journal.pone.0008254
   PubMed Web of Science ®Google Scholar
• Matthews, S. J., & Lancaster, J. W. (2012). Telaprevir: A hepatitis C NS3/4A protease inhibitor. Clinical Therapeutics, 34, 1857–1882. [Review]. doi:10.1016/j.clinthera.2012.07.011
   PubMed Web of Science ®Google Scholar
• Meola, A., Tarr, A. W., England, P., Meredith, L. W., McClure, C. P., Foung, S. K., … Krey, T. (2015). Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies. Journal of Virology, 89, 2170–2181. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.02190-14
   PubMed Web of Science ®Google Scholar
• Merlino, A., Vitagliano, L., Ceruso, M. A., Di Nola, A., & Mazzarella, L. (2002). Global and local motions in ribonuclease A: A molecular dynamics study. Biopolymers, 65, 274–283. [Research Support, Non-U.S. Gov’t]. doi:10.1002/bip.10225
   PubMed Web of Science ®Google Scholar
• Merlino, A., Vitagliano, L., Ceruso, M. A., & Mazzarella, L. (2003). Subtle functional collective motions in pancreatic-like ribonucleases: From ribonuclease A to angiogenin. Proteins: Structure, Function, and Bioinformatics, 53, 101–110. [Research Support, Non-U.S. Gov’t]. doi:10.1002/prot.10466
   PubMed Web of Science ®Google Scholar
• Owsianka, A., Tarr, A. W., Juttla, V. S., Lavillette, D., Bartosch, B., Cosset, F. L., … Patel, A. H. (2005). Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. Journal of Virology, 79, 11095–11104. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.79.17.11095-11104.2005
   PubMed Web of Science ®Google Scholar
• Owsianka, A. M., Tarr, A. W., Keck, Z. Y., Li, T. K., Witteveldt, J., Adair, R., … Patel, A. H. (2008). Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein. Journal of General Virology, 89, 653–659. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. doi:10.1099/vir.0.83386-0
   PubMed Web of Science ®Google Scholar
• Owsianka, A. M., Timms, J. M., Tarr, A. W., Brown, R. J., Hickling, T. P., Szwejk, A., … Ball, J. K. (2006). Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. Journal of Virology, 80, 8695–8704. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.00271-06
   PubMed Web of Science ®Google Scholar
• Pantua, H., Diao, J., Ultsch, M., Hazen, M., Mathieu, M., McCutcheon, K., … Kapadia, S. B. (2013). Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. Journal of Molecular Biology, 425, 1899–1914. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. doi:10.1016/j.jmb.2013.02.025
   PubMed Web of Science ®Google Scholar
• Perotti, M., Mancini, N., Diotti, R. A., Tarr, A. W., Ball, J. K., Owsianka, A., … Burioni, R. (2008). Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein. Journal of Virology, 82, 1047–1052. doi:10.1128/JVI.01986-07
   PubMed Web of Science ®Google Scholar
• Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., … Abrignani, S. (1998). Binding of hepatitis C virus to CD81. Science, 282, 938–941.10.1126/science.282.5390.938
   PubMed Web of Science ®Google Scholar
• Potter, J. A., Owsianka, A. M., Jeffery, N., Matthews, D. J., Keck, Z. Y., Lau, P., … Patel, A. H. (2012). Toward a hepatitis C virus vaccine: The structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody. Journal of Virology, 86, 12923–12932. [Research Support, Non-U.S. Gov’t]. doi:10.1128/JVI.02052-12
   PubMed Web of Science ®Google Scholar
• Roccasecca, R., Ansuini, H., Vitelli, A., Meola, A., Scarselli, E., Acali, S., … Nicosia, A. (2003). Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. Journal of Virology, 77, 1856–1867. [Research Support, Non-U.S. Gov’t].10.1128/JVI.77.3.1856-1867.2003
   PubMed Web of Science ®Google Scholar
• Rychlowska, M., Owsianka, A. M., Foung, S. K., Dubuisson, J., Bienkowska-Szewczyk, K., & Patel, A. H. (2011). Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships. The Journal of general virology, 92(Pt 10), 2249–2261. [Research Support, N.I.H., 80 Extramural Research Support, Non-U.S. Gov’t]. doi:10.1099/vir.0.034314-0.
   PubMed Web of Science ®Google Scholar
• Sandomenico, A., Leonardi, A., Berisio, R., Sanguigno, L., Foca, G., Foca, A., … Ruvo, M. (2016). Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422. Journal of Virology, 90, 3745–3759. doi:10.1128/JVI.02397-15.
   PubMed Web of Science ®Google Scholar
• Triyatni, M., Vergalla, J., Davis, A. R., Hadlock, K. G., Foung, S. K., & Liang, T. J. (2002). Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology, 298, 124–132. [Research Support, U.S. Gov’t, P.H.S.].10.1006/viro.2002.1463
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718. [Research Support, Non-U.S. Gov’t]. doi:10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Zhang, P., Wu, C. G., Mihalik, K., Virata-Theimer, M. L., Yu, M. Y., Alter, H. J., & Feinstone, S. M. (2007). Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proceedings of the National academy of Sciences of the United States of America, 104, 8449–8454. [Research Support, U.S. Gov’t, P.H.S.]. doi:10.1073/pnas.0703039104
   PubMed Web of Science ®Google Scholar